No abstract available
Publication types
-
Case Reports
-
Comparative Study
MeSH terms
-
Anticoagulants / administration & dosage
-
Anticoagulants / adverse effects*
-
Anticoagulants / therapeutic use
-
Antithrombin III / administration & dosage
-
Antithrombin III / therapeutic use
-
Chondroitin Sulfates / administration & dosage
-
Chondroitin Sulfates / therapeutic use
-
Dermatan Sulfate / administration & dosage
-
Dermatan Sulfate / therapeutic use
-
Drug Combinations
-
Female
-
Fibrinolytic Agents / adverse effects*
-
Heparin / adverse effects*
-
Heparitin Sulfate / administration & dosage
-
Heparitin Sulfate / therapeutic use
-
Humans
-
Middle Aged
-
Nadroparin / adverse effects*
-
Necrosis
-
Platelet Count
-
Skin / pathology
-
Skin Diseases / chemically induced*
Substances
-
Anticoagulants
-
Drug Combinations
-
Fibrinolytic Agents
-
Nadroparin
-
Dermatan Sulfate
-
Antithrombin III
-
Heparin
-
Chondroitin Sulfates
-
Heparitin Sulfate
-
danaparoid